Insider Transactions Reported by 15 Insiders of CUMBERLAND PHARMACEUTICALS INC

Symbol
CPIX on Nasdaq
Location
Nashville,, TN

Insiders trading volume in the past year

CUMBERLAND PHARMACEUTICALS INC executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
A. J. KAZIMI Chairman and CEO, Director, 10%+ Owner $24,711,076 +$5,407 +0.02% 01 Dec 2025
Kenneth Krogulski Director $1,159,463 +$28,909 +2.6% 01 Dec 2025
Joseph C. Galante Director $319,796 17 Mar 2025
Martin E. Cearnal Sr VP/Chief Commercial Officer, Director $277,904 17 Mar 2022
Leo Pavliv SVP and Chief Development Off. $220,351 31 May 2022
John Hamm VP Chief Financial Officer $188,442 16 Mar 2025
James Jones Director $176,196 +$5,407 +3.2% 01 Dec 2025
JOEY A. JACOBS Director $167,306 14 Jan 2023
James L. Herman VP and Chief Compliance Office $164,887 17 Mar 2025
Caroline Young Director $130,238 +$2,609 +2% 01 Dec 2025
Todd M. Anthony Vice Pres Organizational Dev $122,614 17 Mar 2025
Chris T. Bitterman Vice Pres Sales & Marketing $91,196 17 Mar 2025
Martin S. Brown JR Director $43,945 17 Mar 2025
Jonathan Griggs Director $25,165 17 Mar 2021
Michael Bonner Chief Financial Officer $19,924 17 Mar 2021

Recent Insider Transactions by Companies or Individuals for CUMBERLAND PHARMACEUTICALS INC

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.